Skip to main content

PHUSE Winter Single Day Event in beautiful Cary, North Carolina.

 PointCross Life Sciences recently collaborated with Sunil Gupta at the PHUSE Winter Single Day Event in beautiful Cary, North Carolina.

Refer to the paper below that introduces a way to automatically map EDC raw data and metadata to SDTMs and ADaMs through the Universal Data Model (UDM) on Xbiom.

Quick brief: The Universal Data Model (UDM) offers an attractive method to traditional SDTM programming and mapping. Non-programmers can access a simple, low-code interface for control and visualization of EDC raw data to SDTM mapping through a universal data model which standardizes all metadata (files, variables, data, etc.).

Xbiom from PointCross comes with built in SDTM conformance rules, and leverages EDC raw data and metadata attributes to strategically compare and map them to SDTM metadata and control terminology variables and derivations. Users then visually review and confirm Xbiom’s recommendations of each SDTM variable mapping and data while Xbiom ‘remembers and learns’ the clinical study’s profile. This greatly helps when EDC raw data is refreshed. Clinical Study Managers and Biomarker Scientists, for example, can focus on continual building of a curated single-truth view of the clinical trial as it progresses since Xbiom tool ‘remembers’ previous data corrections.

➡️ Follow PointCross Life Sciences on LinkedIn

➡️ Visit our website at pointcrosslifesciences.com

#UniversalDataModel #UDM #SDTM #ADaM #clinicalstudies #PhUSE #clinical

Comments

Popular posts from this blog

PointCross Life Sciences launches an automatic SEND Quote Generation tool

  PointCross Life Sciences launches an automatic SEND Quote Generation tool, intended to save industry time and effort in generating a highly competitive, indicative SEND generation or QC quote - including for those requiring a fast-track turnaround. PointCross SEND process ensures a 100% consistency and reconciliation against the GLP Study Report, and is accompanied by the nSDRG, Define, and validation files. SEND studies that PointCross processes or quality checks are also delivered on the Xbiom ™ visualization and analysis platform. Feel free to use the tool (link below) to generate a free, no-commitment indicative quote for your SEND needs, whether it is to generate the full SEND package or 100% QC an existing SEND dataset that you are preparing to submit. Link to SEND Quote Generation tool: https://pointcrosslifesciences.com/send-generation/

Nonclinical Digital Study Report (DSR) - PointCross

  The availability of the Nonclinical Digital Study Report (DSR) is an exciting development that has the promise of making SEND better, safer to use, and actually useful for analysis. DSR is available in machine-readable columnar tabulation, making it easy to use the same tools used to read CDISC ’s SEND. DSR retains the same data domains and terminology of observation and testnames as in the Study Report. DSR is a machine-readable companion to the published PDF Study Report. DSR includes all the required study metadata, trial design domains reflecting the protocol, and the summary tables in the study report. DSR also carries a digital extracts of the Study Director’s “Results and Conclusions” in machine-readable form. A complete DSR may also include the individual subject level findings. SEND is a CDISC standard for exchange of Nonclinical Study Data. In practice, SEND is almost always generated separate from the process that generates the Study Report, but using the same data c...

FDA SEND Dataset Services

The U.S. Food and Drug Administration ( FDA ) requires SEND as a standard for nonclinical study data submission to the Center for Drug Evaluation and Research (CDER). SEND is a data standard mandate of CDISC  SDTM  standard for nonclinical studies and provides a framework to collect and present individual animal study data. PointCross works with several Sponsors’ and CROs to support in preparation of submission ready SEND datasets with Define.xml and nSDRG, at industry’s most competitive rate.